More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$40.64B
EPS
1.98
P/E ratio
--
Price to sales
4.25
Dividend yield
0.404%
Beta
0.982054
Previous close
$82.52
Today's open
$79.95
Day's range
$79.56 - $81.70
52 week range
$71.55 - $99.20
show more
CEO
David J. Endicott
Employees
25000
Headquarters
Fribourg,
Exchange
New York Stock Exchange
Shares outstanding
499700000
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
Here is how Alcon (ALC) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.
Zacks Investment Research • Mar 2, 2026

Alcon Surpasses 175 Million IOLs Implanted Globally
GENEVA--(BUSINESS WIRE)--Alcon Surpasses 175 Million IOLs Implanted Globally.
Business Wire • Mar 2, 2026

Eye-care group Alcon expects product launches to drive 2026 sales, profitability
Alcon on Tuesday forecast 2026 sales growth largely in line with market estimates and guided for a significant expansion in its operating margin, signalling confidence that product launches would drive improved profitability.
Reuters • Feb 25, 2026

Alcon Inc. (ALC) Q4 2025 Earnings Call Transcript
Alcon Inc. (ALC) Q4 2025 Earnings Call Transcript
Seeking Alpha • Feb 25, 2026

Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/Y
ALC's Q4 EPS and revenues lag estimates, sending shares down 3%, even as sales increase 9% and 2026 guidance targets up to 7% growth.
Zacks Investment Research • Feb 25, 2026

Why Alcon (ALC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Feb 25, 2026

Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales
GENEVA--(BUSINESS WIRE)--Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales.
Business Wire • Feb 24, 2026

Alcon (ALC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks Investment Research • Feb 25, 2026

Gear Up for Alcon (ALC) Q4 Earnings: Wall Street Estimates for Key Metrics
Beyond analysts' top-and-bottom-line estimates for Alcon (ALC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.
Zacks Investment Research • Feb 19, 2026

Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology
GENEVA--(BUSINESS WIRE)--Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology.
Business Wire • Feb 17, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Alcon Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.